Defective biliary excretion of copper in Wilson's disease
- PMID: 4820637
- PMCID: PMC1412902
- DOI: 10.1136/gut.15.2.125
Defective biliary excretion of copper in Wilson's disease
Abstract
The biliary excretion of copper was measured in eight patients with Wilson's disease (three untreated, with hepatic dysfunction) and 10 control subjects (three with hepatic dysfunction). The duodenum was perfused with an amino-acid solution containing a non-absorbed marker, (51)CrCl(3), and juice was aspirated from the duodeno-jejunal junction. The mean concentration of copper in the duodenal aspirate in Wilson's disease was significantly lower than in the control group. The mean biliary copper excretion rate in Wilson's disease of 8.6 +/- 0.8 mug/20 min (SEM) was also significantly below that of the control group (16.4 +/- 0.8 mug/20 min). The presence of liver dysfunction made no significant difference to the excretion rates in either group of patients. These results suggest that the copper accumulation in Wilson's disease is due to the inability of the liver to excrete copper into bile in adequate amounts.
Similar articles
-
Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.Eur J Clin Invest. 1996 Oct;26(10):893-901. doi: 10.1111/j.1365-2362.1996.tb02135.x. Eur J Clin Invest. 1996. PMID: 8911863
-
Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.J Lab Clin Med. 1988 Mar;111(3):267-74. J Lab Clin Med. 1988. PMID: 3125292
-
New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.Biochem J. 1996 May 1;315 ( Pt 3)(Pt 3):851-5. doi: 10.1042/bj3150851. Biochem J. 1996. PMID: 8645167 Free PMC article.
-
Wilson's disease: a new gene and an animal model for an old disease.J Investig Med. 1995 Aug;43(4):323-36. J Investig Med. 1995. PMID: 7552582 Review.
-
Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.J Am Coll Nutr. 1990 Oct;9(5):487-91. doi: 10.1080/07315724.1990.10720405. J Am Coll Nutr. 1990. PMID: 2258535 Review.
Cited by
-
The significance of variations in the distribution of copper in liver disease.Am J Pathol. 1980 Jun;99(3):715-30. Am J Pathol. 1980. PMID: 7386600 Free PMC article.
-
Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.Antioxid Redox Signal. 2013 Dec 10;19(17):2024-39. doi: 10.1089/ars.2012.5158. Epub 2013 May 3. Antioxid Redox Signal. 2013. PMID: 23541064 Free PMC article.
-
Practical recommendations and new therapies for Wilson's disease.Drugs. 1995 Aug;50(2):240-9. doi: 10.2165/00003495-199550020-00004. Drugs. 1995. PMID: 8521757 Review.
-
Acute hepatic failure in children.Yale J Biol Med. 1984 Mar-Apr;57(2):161-84. Yale J Biol Med. 1984. PMID: 6433587 Free PMC article. Review.
-
Inherited copper toxicosis in Bedlington terriers: Wilson's disease (hepatolenticular degeneration).Am J Pathol. 1982 Mar;106(3):432-4. Am J Pathol. 1982. PMID: 7065120 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources